SCALP PSORIASIS
Clinical trials for SCALP PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new SCALP PSORIASIS trials appear
Sign up with your email to follow new studies for SCALP PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New treatment tested for embarrassing, itchy skin condition
Disease control CompletedThis study tested how well and safely the drug risankizumab (brand name Skyrizi) works for adults with moderate to severe psoriasis in sensitive areas: the genital region or the scalp. About 214 participants received either the real drug or a placebo via injection for up to a yea…
Matched conditions: SCALP PSORIASIS
Phase: PHASE4 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Breakthrough trial targets psoriasis in understudied populations
Disease control CompletedThis study tested whether the drug guselkumab is safe and effective for treating moderate-to-severe plaque or scalp psoriasis specifically in people with skin of color. It involved 213 participants who identified as non-white or non-Caucasian. The main goal was to see if the drug…
Matched conditions: SCALP PSORIASIS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New shampoo tested for itchy, flaky scalp condition
Symptom relief CompletedThis study tested a special shampoo called Daxxin to see if it safely reduces symptoms of moderate scalp psoriasis. Forty-one adults in Sweden used the shampoo 3 to 7 times a week for 6 weeks. Researchers measured changes in itching, redness, flaking, and quality of life.
Matched conditions: SCALP PSORIASIS
Phase: NA • Sponsor: Daxxin AB • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC